[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"faecal-microbiota-transplantation-fmt\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:faecal-microbiota-transplantation-fmt":46},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":5},"100618487",false,"NCT07332260","Alzheimer's Disease and Faecal Microbiota Transplantation -a Pilot Study","Alzheimer's Disease and Faecal Microbiota Transplantation","AD-FMT","Inclusion Criteria:\n\n* Alzheimer's dementia mild to moderate stage\n* Presence of Alzheimer pathology core 1 biomarkers as defined by National Institute on Aging-Alzheimer's Association (NIA-AA) criteria (2024)\n* Capable of giving informed consent\n\nExclusion Criteria:\n\n* Contraindications for colonoscopy examination\n* Contraindications for Magnetic Resonance Imaging (MRI)\n* Life expectancy \\\u003C 1 year\n* Clinical frailty scale 7 or more\n* History of seizure disorder\n* History of brain tumour or intracranial bleed\n* Major psychiatric disorder such as schizophrenia, bipolar disorder, or major depressive disorder\n* Alcohol or substance abuse\n* Decompensated heart disease\n* Malignancy\n* Current use of anticoagulant treatment (dual acting oral anticoagulant or warfarin)\n* Pregnant or planning pregnancy\n* Colonic adenomas over 1 cm, tumours or signs of active colitis on colonoscopy\n* Status after colectomy or hemicolectomy\n* Inflammatory bowel disease\n* Immunocompromised individual\n* Receiving biological\u002Fantibody treatment","ALL","18 Years",{"count":19,"type":20},10,"ESTIMATED","INTERVENTIONAL",[23],"PHASE1","The goal of this study is to assess the feasibility and safety of faecal microbiota transplantation for Alzheimer's disease.",[26,27],"Alzheimer s Disease","Faecal Microbiota Transplantation (FMT)",[29,30,31,32,33],"Alzheimer's disease","Dementia","Gut microbiota","faecal microbiota transplantation","FMT","RECRUITING","2026-04-17",{"date":37,"type":38},"2026-04-22","ACTUAL",{"date":40,"type":20},"2026-05",{"date":42,"type":20},"2027-01",{"name":44,"class":45},"University Hospital of North Norway","OTHER",""]